Infinium Pharmachem IPO vs Sotac Pharmaceuticals IPO

Comparision between Infinium Pharmachem IPO and Sotac Pharmaceuticals IPO.

IPO Details

Infinium Pharmachem IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Swastika Investmart Ltd	Beeline Capital Advisors Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Kfin Technologies Limited
Market Maker	Swastika Investmart Limited	Sunflower Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.

	Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹105.00 per share
Issue Price (Upper)		₹111.00 per share
Issue Price (Final)	₹135.00 per share	₹111.00 per share
Discount (Retail)
Discount (Employee)	₹13.50 per share
Market Lot Size	1000 shares	1200 shares
Fresh Issue Size	18,75,000 shares	30,00,000 shares
Fresh Issue Size (Amount)	up to ₹25.26 Cr	up to ₹33.30 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	18,75,000 shares	30,00,000 shares
Issue Size Total (Amount)	up to ₹25.26 Cr	up to ₹33.30 Cr

IPO Timetable

Infinium Pharmachem IPO opens on Mar 31, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Infinium Pharmachem IPO and Sotac Pharmaceuticals IPO is Apr 05, 2023, and Apr 03, 2023, respectively.

	Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
Anchor Bid Date		Mar 28, 2023
Issue Open	Mar 31, 2023	Mar 29, 2023
Issue Close	Apr 05, 2023	Apr 03, 2023
Basis Of Allotment (Tentative)	Apr 11, 2023	Apr 10, 2023
Initiation of Refunds (Tentative)	Apr 12, 2023	Apr 11, 2023
Credit of Share (Tentative)	Apr 13, 2023	Apr 12, 2023
Listing date (Tentative)	Apr 17, 2023	Apr 13, 2023
Anchor Lockin End date 1	May 11, 2023	May 10, 2023
Anchor Lockin End date 2	Jul 10, 2023	Jul 09, 2023

Financials

Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.

Infinium Pharmachem IPO

Sotac Pharmaceuticals IPO

Financial

Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	2,244.60	3,941.64	93.40	424.74	566.17
31-Mar-21	3,418.27	7,115.37	272.48	702.32	579.47
31-Mar-22	5,899.95	10,005.25	610.64	1,310.22	1,385.01
30-Sep-22	7,075.71	7,985.39	551.01	1,855.77	1,614.71
Amount in ₹ Lakhs

Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	3,038.21	2,882.64	8.75	305.73	75.73	15.13
31-Mar-21	3,469.75	4,894.97	-236.54	249.36	19.36	1,035.80
31-Mar-22	3,525.35	7,337.02	287.86	662.19	432.19	1,134.59
30-Sep-22	6,461.60	3,994.65	46.55	797.41	567.41	2,185.52
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100%

84.63%

Promoter Shareholding (Post-Issue)

73.05%

P/E Ratio

7.83

132.14

Market Cap

₹93.93 Cr.

₹122.66 Cr.

ROE

6.38%%

ROCE

19.03%%

Debt/Equity

2.74

EPS

RoNW

Shares Offered

In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Sotac Pharmaceuticals IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.

	Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
Anchor Investor Reserveration		8,53,200 shares
Market Maker Reserveration	94,000 shares	1,50,000 shares
QIB	0 shares	5,71,800 shares
NII	9,37,500 shares	4,28,400 shares
RII	9,37,500 shares	9,98,400 shares
Employee	0 shares	0 shares
Others
Total	18,75,000 shares	19,98,600 shares

Bids Received (Subscription)

Infinium Pharmachem IPO subscribed 1.84x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.

	Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
QIB (times)		1.00x
NII (times)	1.80x	4.04x
Big NII (times)
Small NII (times)
RII (times)	1.86x	0.91x
Employee (times)
Other (times)
Total (times)	1.84x	1.60x

Compare with others

Infinium Pharmachem IPO	Sotac Pharmaceuticals IPO
Pattech Fitwell Tube Components IPO	Retina Paints IPO
Sancode Technologies IPO	A G Universal IPO
Exhicon Events IPO	Pattech Fitwell Tube Components IPO
Sotac Pharmaceuticals IPO	Sancode Technologies IPO
MOS Utility IPO	Exhicon Events IPO
Maiden Forgings IPO	MOS Utility IPO
Command Polymers IPO	Infinium Pharmachem IPO
Dev Labtech Venture IPO	Maiden Forgings IPO
Nirman Agri Genetics IPO	Command Polymers IPO
Labelkraft Technologies IPO	Dev Labtech Venture IPO

Comments

Add a public comment...